https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2025-06-03 12:03:342025-06-03 12:03:34Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2025-06-03 12:03:332025-06-03 12:03:33ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2025-06-03 12:03:312025-06-03 12:03:31Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
